Home7EY • FRA
add
Kiora Pharmaceuticals Inc
Year range
€0.42 - €0.42
Market cap
7.62M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.46M | 9.88% |
Net income | -6.52M | -54.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.62M | -4.78% |
Effective tax rate | 9.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.09M | -36.22% |
Total assets | 24.25M | -33.52% |
Total liabilities | 8.13M | -24.22% |
Total equity | 16.13M | — |
Shares outstanding | 3.95M | — |
Price to book | — | — |
Return on assets | -24.30% | — |
Return on capital | -33.45% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.52M | -54.29% |
Cash from operations | -2.18M | 3.19% |
Cash from investing | 5.35M | 1,008.21% |
Cash from financing | 296.00 | — |
Net change in cash | 3.19M | 272.76% |
Free cash flow | -1.68M | -300.17% |
About
Founded
1998
Headquarters
Website
Employees
12
